Spots Global Cancer Trial Database for Digital 3D Breast Tomosynthesis Versus 2D in Clinical Evaluation of High Risk Women
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Digital 3D Breast Tomosynthesis Versus 2D in Clinical Evaluation of High Risk Women
Official Title: 3D Digital Breast Tumorsynthesis Versus 2D Digital Mammography in the Clinical Evaluation of Women at High Risk for Breast Cancer
Study ID: NCT02209129
Conditions
Interventions
Study Description
Brief Summary: Patients with a higher breast cancer risk (higher than 17% according to the IBIS calculation) will receive a 2D digital mammography together with a 3D tomosynthesis (so called combo tomo) of both breasts in two views in order to investigate the additional value of tomosynthesis in the diagnosis of breast cancer.
Detailed Description:
Keywords
Eligibility
Minimum Age: 40 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
UZLeuven, Leuven, , Belgium
Contact Details
Name: Chantal Van Ongeval, MD,Phd
Affiliation: Universitaire Ziekenhuizen KU Leuven
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
